Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana
- PMID: 17961284
- DOI: 10.1017/S0031182007003848
Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana
Abstract
Leishmania (Viannia) braziliensis and L. (V.) peruviana are two parasite species characterized by a very different pathogenicity in humans despite a high genetic similarity. We hypothesized previously that L. (V.) peruviana would descend from L. (V.) braziliensis and would have acquired its 'peruviana' character during the southward colonization and adaptation of the transmission cycle in the Peruvian Andes. In order to have a first appreciation of the differences in virulence between both species, we evaluated an in vitro and in vivo model for experimental infection. A procedure was adapted to enrich culture forms in infective stages and the purified metacyclics were used to infect macrophage cell lines and golden hamsters. The models were tested with 2 representative strains of L. (V.) braziliensis from cutaneous and mucosal origin respectively and 2 representative strains of L. (V.) peruviana from Northern and Southern Peru respectively. Our models were reproducible and sensitive enough to detect phenotypic differences among strains. We showed in vitro as well as in vivo that the L. (V.) braziliensis was more infective than L. (V.) peruviana. Furthermore, we found that in vitro infectivity patterns of the 4 strains analysed, were in agreement with the geographical structuring of parasite populations demonstrated in our previous studies. Further work is needed to confirm our results with more strains of different geographical origin and their specific clinical outcome. However, our data open new perspectives for understanding the process of speciation in Leishmania and its implications in terms of pathogenicity.
Similar articles
-
Comparative zymographic analysis of metallopeptidase of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis isolates from Peru.Parasitol Int. 2012 Dec;61(4):513-9. doi: 10.1016/j.parint.2012.03.007. Epub 2012 Mar 30. Parasitol Int. 2012. PMID: 22562004
-
Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo.Parasitol Int. 2009 Mar;58(1):45-50. doi: 10.1016/j.parint.2008.09.006. Epub 2008 Oct 25. Parasitol Int. 2009. PMID: 18992366
-
In vitro and in vivo behaviour of sympatric Leishmania (V.) braziliensis, L. (V.) peruviana and their hybrids.Parasitology. 2012 Feb;139(2):191-9. doi: 10.1017/S0031182011001909. Epub 2011 Nov 7. Parasitology. 2012. PMID: 22054424
-
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.Parasite Immunol. 2009 Aug;31(8):423-31. doi: 10.1111/j.1365-3024.2009.01116.x. Parasite Immunol. 2009. PMID: 19646206 Review.
-
From population to genome: ecogenetics of Leishmania (Viannia) braziliensis and L. (V.) peruviana.Ann Trop Med Parasitol. 1995 Dec;89 Suppl 1:45-53. doi: 10.1080/00034983.1995.11813014. Ann Trop Med Parasitol. 1995. PMID: 8745927 Review.
Cited by
-
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis.Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02048-16. doi: 10.1128/AAC.02048-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28137819 Free PMC article.
-
Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates.PLoS Negl Trop Dis. 2011 May 10;5(5):e1021. doi: 10.1371/journal.pntd.0001021. PLoS Negl Trop Dis. 2011. PMID: 21572980 Free PMC article.
-
Stimulation of metacyclogenesis in Leishmania (Mundinia) orientalis for mass production of metacyclic promastigotes.Front Cell Infect Microbiol. 2022 Sep 5;12:992741. doi: 10.3389/fcimb.2022.992741. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36132986 Free PMC article.
-
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.Int J Parasitol Drugs Drug Resist. 2019 Dec;11:106-117. doi: 10.1016/j.ijpddr.2019.06.003. Epub 2019 Jun 20. Int J Parasitol Drugs Drug Resist. 2019. PMID: 31320296 Free PMC article. Review.
-
BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.PLoS Negl Trop Dis. 2011 Mar 1;5(3):e965. doi: 10.1371/journal.pntd.0000965. PLoS Negl Trop Dis. 2011. PMID: 21390155 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources